CDC MMWR Highlights Progress Toward UNAIDS Global HIV PrEP Targets

On November 27, 2024, CDC issued in its Morbidity and Mortality Weekly Report (MMWR) data on CDC-supported uptake of pre-exposure prophylaxis (PrEP) in 37 countries from 2017-2023. A summary of the report is below.

Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 2017─2023

Summary

What is already known about this topic?

Pre-exposure prophylaxis (PrEP) reduces the risk for HIV acquisition from sex by 99% and from injection drug use by ≥74% when used as recommended. Globally, 3.5 million persons initiated or continued PrEP during 2023, far fewer than the United Nations Programme on HIV/AIDS goal of at least 21.2 million persons initiating or continuing PrEP globally during 2025.

What is added by this report?

During 2017–2023, CDC supported 2,278,743 PrEP initiations in 37 countries, 118.7% of CDC’s overall target for the 7-year period; 856,816 of the initiations occurred in 2023.

What are the implications for public health practice?

Additional scale-up is needed to meet the goal of 21.2 million persons using PrEP globally in 2025.

Read the complete report here.